Search - tctmd.com

Displaying 801 - 820 of 1353

Sort: Relevancy | Date

Viper Peptides Explored Anew as Antiplatelet Drugs

News Daily News

Viper Peptides Explored Anew as Antiplatelet Drugs

Yael L. Maxwell

June 08, 2017

Avoiding Autopsy: CT and Coronary Angiography Can Play a Role Postmortem

News Daily News

Avoiding Autopsy: CT and Coronary Angiography Can Play a Role Postmortem

June 06, 2017

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

News Daily News

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

Michael O'Riordan

May 31, 2017

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

News Daily News

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

May 17, 2017

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

News Daily News

Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk

Yael L. Maxwell

May 15, 2017

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

May 15, 2017

Very Low Radiation Doses With SPECT MPI Are Possible

News Daily News

Very Low Radiation Doses With SPECT MPI Are Possible

May 08, 2017

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

News Daily News

Benefits of FFR-Guided Complete Revascularization in STEMI May Be Limited to Most Severe Disease

April 21, 2017

Who Should Get a Statin? Guidelines Don’t Match Up

News Daily News

Who Should Get a Statin? Guidelines Don’t Match Up

Michael O'Riordan

April 20, 2017

One in Five Acute MI Patients Drop Statins Within 2 Years

News Daily News

One in Five Acute MI Patients Drop Statins Within 2 Years

Michael O'Riordan

April 20, 2017

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

News Daily News

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yael L. Maxwell

April 17, 2017

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

News Daily News

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Yael L. Maxwell

April 11, 2017

Readmission for Critical Limb Ischemia Common and Largely Unplanned

News Daily News

Readmission for Critical Limb Ischemia Common and Largely Unplanned

April 10, 2017

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

News Daily News

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

April 10, 2017

Yo-Yo a No-No: Fluctuating Body Weight May Increase Morbidity and Mortality Among CAD Patients

News Daily News

Yo-Yo a No-No: Fluctuating Body Weight May Increase Morbidity and Mortality Among CAD Patients

April 06, 2017

Absorb BVS Use Restricted in Europe

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

News Daily News

ACC/AHA ‘Very High Risk’ Criteria Only Modestly Predict Recurrent Events

Michael O'Riordan

April 04, 2017

Opened Data: Analysis of Requests for NHLBI Trial Data May Allay Some Concerns

News Daily News

Opened Data: Analysis of Requests for NHLBI Trial Data May Allay Some Concerns

March 29, 2017

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.